Laurion Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-195,663
| Closed | -$21M | – | 491 |
|
|
2023
Q1 | $21M | Sell |
195,663
-235
| -0.1% | -$25.2K | 0.14% | 25 |
|
|
2022
Q4 | $21.5M | Sell |
195,898
-31,610
| -14% | -$3.48M | 0.1% | 28 |
|
|
2022
Q3 | $13.4M | Sell |
227,508
-659
| -0.3% | -$38.9K | 0.08% | 55 |
|
|
2022
Q2 | $6.44M | Sell |
228,167
-100,000
| -30% | -$2.82M | 0.1% | 51 |
|
|
2022
Q1 | $12.4M | Hold |
328,167
| – | – | 0.15% | 35 |
|
|
2021
Q4 | $13M | Buy |
328,167
+159,369
| +94% | +$6.3M | 0.13% | 51 |
|
|
2021
Q3 | $4M | Buy |
168,798
+106,714
| +172% | +$2.53M | 0.02% | 158 |
|
|
2021
Q2 | $1.53M | Buy |
62,084
+12,084
| +24% | +$297K | 0.01% | 184 |
|
|
2021
Q1 | $913K | Buy |
+50,000
| New | +$913K | ﹤0.01% | 309 |
|